健康生活方式与英国生物银行多病共存人群的预期寿命:纵向队列研究
该研究基于英国生物银行480,940名中年参与者,随访至2016年,发现无论是否存在多病共存,更健康的生活方式与男性最多延长6.3年、女性7.6年寿命相关,其中不吸烟生存获益最大。
要点
- 多病共存者中,非常健康生活方式与男性延长6.3年、女性7.6年寿命相关。
- 不吸烟是单个生活方式因素中生存获益最大的因素。
- 健康生活方式评分越高,预期寿命增益越大,且无多病共存者结果一致。
核心结论
- 无论是否多病共存,更健康生活方式与男性最多延长6.3年、女性7.6年寿命相关。
- 并非所有生活方式危险因素与预期寿命的相关性相同,吸烟显著劣于其他因素。
研究设计与样本
- 英国生物银行纵向队列研究,纳入480,940名中年成人(中位年龄58岁,范围38-73,46%男性,95%白人)。
- 2006-2010年收集数据,随访至2016年,平均随访7年(范围2-9年)。
- 提取36种慢性病,多病共存定义为≥2种慢性病。
- 基于国家指南采用4种生活方式因素:休闲时间体力活动、吸烟、饮食、饮酒,构建加权评分分为4组。
- 采用生存模型预测预期寿命,调整种族、工作状态、贫困程度、体重指数和久坐时间。
主要发现
- 93,746名(19.5%)参与者有多病共存,随访期间发生11,006例死亡。
- 45岁时,多病共存男性中,不健康评分较非常不健康评分增加1.5年(95%CI -0.3至3.3;P=0.102),不显著。
- 多病共存男性中,健康评分显著增加4.5年(95%CI 3.3至5.7;P<0.001),非常健康评分增加6.3年(95%CI 5.0至7.7;P<0.001)。
- 多病共存女性中,不健康、健康、非常健康评分分别增加3.5年(95%CI 0.7至6.3;P=0.016)、6.4年(95%CI 4.8至7.9;P<0.001)、7.6年(95%CI 6.0至9.2;P<0.001)。
- 无多病共存者及多项敏感性分析结果一致;不吸烟与最大生存获益相关。
临床怎么用
- 在多病共存人群中推广健康生活方式仍可显著延长预期寿命,不应因多病共存而忽视生活方式干预。
- 戒烟应作为多病共存者生活方式干预的重中之重,因其生存获益最大。
- 健康生活方式评分越高,预期寿命增益越大,可鼓励多病共存者向更高评分改善。
局限性
- 无法使用仅包含心血管代谢疾病的更严格多病共存定义来探索结果的一致性。
- 参与者不能代表整个英国人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether a healthy lifestyle impacts longevity in the presence of multimorbidity is unclear. We investigated the associations between healthy lifestyle and life expectancy in people with and without multimorbidity. METHODS AND FINDINGS: A total of 480,940 middle-aged adults (median age of 58 years [range 38-73], 46% male, 95% white) were analysed in the UK Biobank; this longitudinal study collected data between 2006 and 2010, and participants were followed up until 2016. We extracted 36 chronic conditions and defined multimorbidity as 2 or more conditions. Four lifestyle factors, based on national guidelines, were used: leisure-time physical activity, smoking, diet, and alcohol consumption. A combined weighted score was developed and grouped participants into 4 categories: very unhealthy, unhealthy, healthy, and very healthy. Survival models were applied to predict life expectancy, adjusting for ethnicity, working status, deprivation, body mass index, and sedentary time. A total of 93,746 (19.5%) participants had multimorbidity. During a mean follow-up of 7 (range 2-9) years, 11,006 deaths occurred. At 45 years, in men with multimorbidity an unhealthy score was associated with a gain of 1.5 (95% confidence interval [CI] -0.3 to 3.3; P = 0.102) additional life years compared to very unhealthy score, though the association was not significant, whilst a healthy score was significantly associated with a gain of 4.5 (3.3 to 5.7; P < 0.001) life years and a very healthy score with 6.3 (5.0 to 7.7; P < 0.001) years. Corresponding estimates in women were 3.5 (95% CI 0.7 to 6.3; P = 0.016), 6.4 (4.8 to 7.9; P < 0.001), and 7.6 (6.0 to 9.2; P < 0.001) years. Results were consistent in those without multimorbidity and in several sensitivity analyses. For individual lifestyle factors, no current smoking was associated with the largest survival benefit. The main limitations were that we could not explore the consistency of our results using a more restrictive definition of multimorbidity including only cardiometabolic conditions, and participants were not representative of the UK as a whole. CONCLUSIONS: In this analysis of data from the UK Biobank, we found that regardless of the presence of multimorbidity, engaging in a healthier lifestyle was associated with up to 6.3 years longer life for men and 7.6 years for women; however, not all lifestyle risk factors equally correlated with life expectancy, with smoking being significantly worse than others.
引用
- Chudasama YV, Khunti K, Gillies CL, et al. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study. PLoS Med. 2020. PMID: 32960883. doi:10.1371/journal.pmed.1003332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。